Specialty Pharmaceuticals: Solving the Encore Problem
This article was originally published in Start Up
Executive Summary
Even the most successful specialty pharmas hit a point where an in-licensing candidate has to be almost too costly in order to sustain the growth of the organization. Start-ups are trying to avoid this trap by developing capabilities that add significant value to an in-licensing candidate, or by having at the outset some approach to identifying products and niches that no one else can.